Biocon gets EIR from USFDA for Bengaluru biologics unit Medical Dialogues Bureau6 Nov 2019 3:49 AMNew Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system Medical Dialogues Bureau5 Nov 2019 7:35 AMThe U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility Medical Dialogues Bureau5 Nov 2019 7:27 AMNew Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr Medical Dialogues Bureau5 Nov 2019 7:25 AMNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA Medical Dialogues Bureau4 Nov 2019 11:01 AMNew Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
GSK Benlysta gets European nod for treatment of children with lupus Medical Dialogues Bureau4 Nov 2019 3:45 AMNew Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
AbbVie says multiple parties vying for assets related to Allergan deal approval Medical Dialogues Bureau4 Nov 2019 3:30 AMAbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office Medical Dialogues Bureau3 Nov 2019 4:25 AM"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake Medical Dialogues Bureau3 Nov 2019 4:15 AMThe USFDA on Wednesday placed a partial hold on a Novartis trial of the $2.1 million-per-patient gene therapy, Zolgensma after the company informed...
Amgen to reduce price of its cholesterol drug Repatha starting 2020 Medical Dialogues Bureau3 Nov 2019 3:45 AMAmgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial Medical Dialogues Bureau3 Nov 2019 3:30 AMBristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
Andhra Pradesh: Blast at Chemist shop, 2 dead Farhat Nasim2 Nov 2019 10:55 AMThough the cause of the fire is unknown, yet it is suspected that a blast in the AC compressor caused the incident. The cops found the dead body of...
